01.01.08
Indication: Overweight and obesity
Source: Phytother Res, December 2007;21(12):1177-81.
Research: Investigators initiated a double-blind, randomized, parallel-group, placebo-controlled study in order to evaluate the effect of orally self-administered Slim339, which is a proprietary fixed combination of Garcinia cambogia extract with calcium pantothenate (standardized for the content of hydroxycitric acid and pantothenic acid) and extracts of Matricaria chamomilla, Rosa damascena, Lavandula officinalis and Cananga odorata, on body weight in overweight and obese volunteers.
Results: During the 60-day treatment period, the average reduction in body weight for the group receiving Slim339 (n = 30) was nearly 5% compared with less than 1% for the placebo group (n = 28). Weight losses of >/=3 kg were recorded for 23 subjects in the treatment group and only one in the placebo group. As a result of these findings, researchers believe Slim339 represents a potential therapy for obesity.
Source: Phytother Res, December 2007;21(12):1177-81.
Research: Investigators initiated a double-blind, randomized, parallel-group, placebo-controlled study in order to evaluate the effect of orally self-administered Slim339, which is a proprietary fixed combination of Garcinia cambogia extract with calcium pantothenate (standardized for the content of hydroxycitric acid and pantothenic acid) and extracts of Matricaria chamomilla, Rosa damascena, Lavandula officinalis and Cananga odorata, on body weight in overweight and obese volunteers.
Results: During the 60-day treatment period, the average reduction in body weight for the group receiving Slim339 (n = 30) was nearly 5% compared with less than 1% for the placebo group (n = 28). Weight losses of >/=3 kg were recorded for 23 subjects in the treatment group and only one in the placebo group. As a result of these findings, researchers believe Slim339 represents a potential therapy for obesity.